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a  b  s  t  r  a  c  t
Hecogenin  is  a sapogenin  found  in  Agave  species  in high  quantities  and  is  responsible  for  the  many
therapeutic  effects  of  these  medicinal  plants.  In addition,  this  compound  is also  widely used  in  the  phar-
maceutical  industry  as  a precursor  for the  synthesis  of  steroidal  hormones  and  anti-inﬂammatory  drugs.
Despite  Hecogenin  being  widely  used,  little  is known  about  its toxicological  properties.  Therefore,  the
present  study  aimed  to investigate  the  cytotoxic,  genotoxic  and  mutagenic  effects  of  Hecogenin  on  HepG2
cells.  Cytotoxicity  was  analyzed  using  the  MTT test. Then,  genotoxic  and  mutagenic  potentials  were
assessed  by comet  assay  and  cytokinesis-block  micronucleus  assay,  respectively.  Cytotoxic  effect  was
observed  only  when  cells  were  exposed  to concentrations  of  Hecogenin  equal  or higher than  100  M.enotoxicity
omet assay
Although  a lower  concentration  of Hecogenin  caused  DNA  damage,  a  reduction  on  nuclear  mutagenic
markers  in  HepG2  cells  was  observed.  The  results  indicated  that  Hecogenin  treatment  generated  DNA
damage,  but  in  fact  it would  be repaired,  avoiding  dissemination  of the  damage  throughout  the  cell divi-
sion.  Further  studies  need  to be  performed  to conﬁrm  the  observed  protective  effect of Hecogenin  against
genomic  instability.
©  2016  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the CC. Introduction
Sapogenins are the non-polar residue of amphipathic glyco-
ides named Saponins [1]. The therapeutic properties of different
lasses of saponins such as analgesic, anti-inﬂammatory and anti-
umoral effects have already been demonstrated [2]. Furthermore,
apogenins are of great interest for the pharmaceutical industry as
 source for the development of new drugs [3].
Hecogenin is a sapogenin found in Agave sisalana species (com-
only known as “sisal”), which are extensively spread throughout
ropical and subtropical regions [4]. Brazil is one of the largest
roducers of sisal, representing 69% of worldwide production [5].
lants of the Agave genus are used as therapeutic agents by Chi-
ese Traditional Medicine in scabiosis, in reducing pain, treating
ifferent inﬂammatory conditions and even against cancer [6].
∗ Corresponding author at: Departamento de Biologia Celular e Genética, Univer-
idade Federal do Rio Grande do Norte, Av. Sen. Salgado Filho 3000–Lagoa Nova, CEP
9078-970, Natal, RN/Brazil.
E-mail address: vi.mariga@gmail.com (V. Souza do Amaral).
ttp://dx.doi.org/10.1016/j.toxrep.2016.06.004
214-7500/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access
c-nd/4.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Hecogenin has been indicated as the responsible agent
for sisal therapeutic effect due to its beneﬁcial properties
involving anti-inﬂammatory, antioxidant, antifungal, hypotensive,
anti-hyperalgesic and anti-nociceptive effects [7–9]. Moreover,
Hecogenin is used in the pharmaceutical industry as a precursor
of steroidal anti-inﬂammatory and steroidal hormone drugs [10].
Despite Hecogenin being widely used and its beneﬁcial effects,
information about its toxicity is still very scarce. Currently, the
information available about Hecogenin toxicological effects has
been tested using a high concentration of Hecogenin-rich extracts
on animal models [11]. Unlike animal models, in vitro cell-based
models provide mechanistic understanding and present some
advantages such as simplicity, low cost, and reproducibility. They
are commonly used in basic science for pharmaceutical research
along with toxicological investigation [12].
In the literature, studies aimed to investigate Hecogenin mech-
anisms of cytotoxicity have been reported using different cell lines
such as A549 human lung cancer cell, human rheumatoid arthri-
tis synovial cell and 1547 osteosarcoma cell lines [13–15]. These
cell lines are interesting models to investigate cytotoxic and anti-





















































H40 M.S. Cruz et al. / Toxicolo
umoral properties of a diversity of substances, but since Hecogenin
s used as a medicinal molecule, it is important to take into account
oxicology in environments that allow metabolization, simulating
hat happens in live organisms [16]. For instance, the Human hep-
toma cell line (HepG2) that contains endogenous metabolizing
nzymes is an in vitro model that helps to assess xenobiotics that
eed a previous bioactivation [17]. Until now, there have been no
eports of Hecogenin toxicity using this cell line. In addition, genetic
oxicology helps understand the deleterious effect in a subclini-
al stage caused by exposure to different toxic substances [18].
sing genetic biomarkers on this cell model would broaden the
cope of the toxicological assessment. Therefore, this work aimed to
ssess cytotoxic, genotoxic and mutagenic potentials of Hecogenin
n HepG2 cells.
. Materials and methods
.1. Reagents and compounds
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
MTT), cytochalasin B, cyclophosphamide, Giemsa dye, silver
itrate and SYBR Green were purchased from Sigma-Aldrich
St. Louis, MO,  EUA). Normal-melting point (NMP) agarose, low-
elting point (LMP) agarose, Dulbecco’s modiﬁed Eagle’s medium
DMEM), streptomycin/penicillin, fetal bovine serum and trypsin
ere acquired from Life Technologies (Carlsbad, CA, EUA).
.2. Hecogenin extraction from A. sisalana
Hecogenin was kindly provided by Prof. Dr. José Maria
arbosa-Filho, from the Pharmaceutical Sciences Department,
FPB. Protocol for the isolation, puriﬁcation and identiﬁcation per-
ormed for obtaining Hecogenin from A. sisalana is detailed in
erqueira et al. [7]. First, 5 kg of A. sisalana leaves were extracted
ith ethanol using a soxhlet dispositive for 24 h. Afterward, sol-
ent was removed under reduced pressure and the residue was
ydrolyzed by reﬂuxing with ethanolic hydrochloric acid for 4 h.
fter cooling and ﬁltering, the acid-insoluble residue was extracted
ith hexane in a soxhlet apparatus for 12 h and the extract was  re-
rystallized with acetone and analyzed by MNR  for identiﬁcation.
he Hecogenin was extracted by acetylation with an acetic anhy-
ride/pyridine mixture, then the isolated Hecogenin was analyzed
y HPLC and the purity reached 98%.
Hecogenin dry powder was suspended in acetone before use.
he ﬁnal acetone concentration in culture was less than 1%, as
ndicated by Burgess et al. [19].
.3. HepG2 cell culture
Human hepatoma cell lines (HepG2) were purchased from an
merican Culture Collection (ATCC, Rockville, MD). First, cells were
ultivated in DMEM medium, supplemented with 10% fetal bovine
erum, 1% streptomycin/penicillin and 2% l-glutamine at 37 ◦C and
% CO2.
.4. Cell viability assessment (MTT test)
The MTT  assay was performed to determine cell viability
hrough the energetic cell metabolism. First, the MTT salt is reduced
y succinic dehydrogenase in mitochondria to formazan, an insol-
ble violet crystal [20]. The MTT  assay was performed following
he protocol previously described by Mosmann [21] with minor
odiﬁcations. Then, 104 cells per well were seeded in 96-well
at bottom culture plates and incubated overnight at 37 ◦C and
% CO2. After incubation, cells were exposed to concentrations of
ecogenin between 0 M (negative control: medium + 1% vehicle),ports 3 (2016) 539–543
10 M,  50 M,  100 M,  150 M and 200 M for 24 h. MTT  was
added at a ﬁnal concentration of 1 mg/mL  and incubated for 4 h.
Then, the medium was  removed and 100% ethanol was added to
dissolve the formed formazan crystals. Absorbance was determined
at 570 nm in a spectrophotometer. The experiment was performed
three times independently.
2.5. Genotoxic assessment (Comet assay)
Comet assay was  performed to investigate the genotoxic effect
of Hecogenin. This assay is based on the fact that damaged
DNA loses its association with nuclear proteins while undam-
aged DNA does not. The resulting DNA fragments as consequence
of the genetic damage can be observed microscopically after
electrophoresis as “comets”, and the degree of DNA damage is esti-
mated considering the tail size, the integrity of the nucleoid and
the relationship of both [22].
Comet assay was performed as previously described [22] with
minor modiﬁcations. First, cells were seeded in 6-well plates and
treated with four different concentrations of hecogenin, 0 M (neg-
ative control: medium + 1% vehicle), 10 M,  25 M and 50 M, and
30 M of H2O2 (positive control) for 24 h. Cell suspension was
mixed with 1% (w/v) low-melting agarose and loaded onto slides
pre-coated with 1.5% (w/v) normal melting agarose. After agarose
solidiﬁcation, the slides were submerged in lysis buffer (2.5 M NaCl,
100 mM EDTA, 10 mM Tris-HCl with 10% DMSO and 1% Triton X –
100 freshly added; pH 10.0; 3 h). Then, the nucleoids were sub-
merged in electrophoresis buffer (10 M NaOH and 200 mM EDTA;
pH 13.0, 4 ◦C) for 20 min  for DNA denaturation. Electrophoresis was
conducted for 30 min  at 30 V and 400 mA.  Afterward, the slides
were washed with neutralization buffer (0.4 M of Tris-HCl buffer;
pH 7.5) and absolute ethanol. Slides were stained with 0.02% silver
nitrate solution, according to Nadin et al. [23].
Fifty nucleoids per experiment were visually scored in an optical
microscope (Olympus, Japan), totalizing 150 nucleoids per treat-
ment, as described by Collins et al. [24]. Each comet was  given an
arbitrary unit of 0–4 (0–undamaged; 4–maximum damage). Dam-
age score was thus assigned to each sample ranging from 0 (no
damage: 50 cells x 0) to 200 (maximum damage: 50 cells x 4). Then,
a mean was  calculated for each treatment.
2.6. Mutagenicity assessment (CBMN assay)
DNA damage that overcame the repairing process can progress
to chromosome abnormalities causing a mutagenic effect. Micronu-
clei (MN) characterized by lost genetic material from DNA double
strand breaks acquiring the morphology of a small nucleus is one of
resulting genetic consequence that can be seen in cells affected by
mutagen substances and has been extensively used as a biomarker
of mutagenicity. Moreover, other cytological characteristics help us
understand the resulting genetic instability. For instance, ampliﬁed
genes could be excluded from the nucleus, leaving a nucleoplasmic
connection between it and the main nucleus, or could also be cre-
ated from dicentric chromosomes that can form a continuous link
between the nuclei in a binucleated cell. These clastogenic or aneu-
genic effects are characterized by the occurrence of nuclear buds
(NBUDs), and nucleoplasmic bridges (NBRDs) [18,25].
The CBMN assay was performed according to the protocol
described by Vasquez et al. [26], with minor modiﬁcations. First,
HepG2 cells (5 × 105) were seeded in 6-well plates and allowed
to attach overnight. Then, the cells were treated with 0 M (neg-
ative control: medium + 1% vehicle), 10 M,  25 M and 50 M of
Hecogenin, and positive control (cyclophosphamide 0.2 mg/mL)
for 24 h. Afterward, cytochalasin B was  added (ﬁnal concentra-
tion, 3.5 g/mL) following 24 h of incubation. Cells were washed
with hypotonic solution (0.075 M KCl, 4 ◦C, 3 min) and ﬁxed with



























NFig. 1. Cytotoxic effect of Hecogenin by MTT  test.
ethanol and acetic acid (9:1). Slides were stained with 5% Giemsa
olution and analyzed under light microscopy.
The Nuclear Division Index (NDI) is a useful parameter for com-
aring the cytostatic effects of substances evaluated in CBMN assay
25]. Five hundred viable cells were counted to determine NDI
sing the following formula [27]: NDI = (M1 + 2 M2 + 3 M3 + 4 M4)/N,
here M1, M2, M3 and M4 are the number of cells with one, two,
hree and four (or more) nuclei and N is the number of assayed cells.
or micronucleus (MN), nuclear bud (NBUD) and nuclear bridge
NBRD) quantiﬁcation, 1000 binucleated cells were blind-scored in
hree independent experiments. The number of alterations in bin-
cleated cells was determined following the examination criteria
eported by Fenech [18].
.7. Statistical analysis
Comparison of the results among treatments was  performed
y Kruskal-Wallis test and the difference between groups was
ssessed by Mann-Whitney U test. Statistical differences were set
or p ≤ 0.05. The statistical analysis was performed using SPSS soft-
are version 20.
. Results
MTT  assay was performed to assess the Hecogenin cytotox-
city. When treated with 10 M and 50 M of Hecogenin, the
ells converted MTT  to formazan in a quantity similar to negative
ontrol (culture medium + vehicle), revealing minimal changes in
bsorbance spectrum. Therefore, no cytotoxic effect was  observed
n HepG2 cells in this range of concentrations (Fig. 1). On the
ther hand, exposure to 100 M of Hecogenin demonstrated a
able 1
enotoxic effect of Hecogenin using Comet Assay on HepG2 cells.
Concentration Number of cells in each comet class (mean ± SD) 
0 1 2 
NC 25.7 ± 1.2 19.0 ± 2.2 2.3 ± 0.5 
PC  0 * 0 * 9.0 ± 3.5*
10 M 19.3 ± 1.7* 13.3 ± 0.5* 6.3 ± 0.9*
25 M 16.0 ± 1.4* 20.8 ± 2.7 4.7 ± 1.2*
50 M 15.3 ± 1.7* 16.3 ± 3.4 7.3 ± 2.9*
C: Negative Control; PC: Positive Control (30 M H2O2).
* Means p > 0.05.Fig. 2. Mutagenic effect by CBMN test of Hecogenin. NC: Negative Control; MN:
Micronucleus; NBUD: Nuclear Buds; NBRD: Nuclear Bridges.
slight reduction in cell viability, although it did not reach statisti-
cal signiﬁcance. In treatments over 100 M,  cell viability decreased
signiﬁcantly by about 30%.
Comet assay was performed to evaluate genotoxic potential of
Hecogenin. The results showed that all treatments of Hecogenin
were capable of causing both overall DNA damage about two times
the basal value observed in negative control, and also an increased
frequency of high damage score (class 4) 4–6 times higher than the
control (Table 1).
To assess mutagenic effect, CBMN assay was performed on
HepG2 cells exposed to Hecogenin for 24 h. A reduction in NDI
showed a signiﬁcant cytostatic effect at Hecogenin concentrations
of 25 M and 50 M.  On the other hand, a reduction in MN  and
NBUD frequency was observed in every treatment assessed (Fig. 2).
4. Discussion
Natural products used in traditional medicine are currently
studied as potential sources of active principles for the treatment
of different illness. Sapogenine-rich plants have shown many ther-
apeutic properties [2,3].
Nevertheless, the information in literature about cytotoxicity,
genotoxicity and mutagenicity can have discrepancies, depending
on the sapogenin or saponin studied. For instance, Corbiere et al.
[28], using an Osteosarcoma cell line found Hecogenin cytotoxic
effect two-fold lower than that observed when testing diosgenin
using the MTT  test. In addition, the applied cellular model can
show variability in the obtained results. For instance, Liagre et al.
[14] reported a cytotoxic effect of Hecogenin through MTT  assay in
Human Rheumatoid Arthritis Fibroblasts-like synoviocyte cell line
exposed to 40 M,  for 24 h. Also, Trouillas et al. [15] demonstrated
a cytotoxic effect with a similar concentration and exposure time of
Hecogenin in Human 1547 Osteosarcoma cells using the MTT  test.
In contrast, Fernández-Herrera et al. [29], described low cytotoxic-
ity from assayed Hecogenin derivatives using three different types
of cancer cell lines.
Damage Score (mean ± SD)
3 4
2.0 ± 1.4 1.0 ± 0.0 33.7 ± 2.5
23.0 ± 4.3* 18.0 ± 1.3* 159.0 ± 17.0*
4.7 ± 1.2 6.4 ± 0.5* 65.3 ± 3.4*
4.0 ± 1.4 4.5 ± 0.7* 56.7 ± 9.3*
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In this work, Hecogenin cytotoxic effect was observed at con-
entrations equal or higher than 100 M.  The difference in the
oncentrations between the aforementioned studies and this work
ould be related to additional characteristics of the applied cellular
odel. For instance, in contrast with the other studies, Hecogenin
as assessed on HepG2 cells, which have an endogenous capac-
ty to biotransform xenobiotics [17]. A reduction in the Hecogenin
oxicity could have taken place through a biotransformation pro-
ess with a decrease in the resulting toxicity, as has been previously
escribed for other natural products [30]. In addition, a cytostatic
ffect was observed. This fact was in agreement with a cell cycle
rrest and an anti-proliferative effect on tumoral cells which have
een previously described [28,29,31].
The genotoxic and antigenotoxic effects of some saponins (the
arent drug) have been described. For instance, Liu et al. [32]
eported the ability of a mix  of saponins extracted from plants of
he Nuclea genus, widely used in African traditional medicine, to
licit DNA damage when tested on Chinese Hamster Ovary cells.
n the other hand, the antigenotoxic effect of saponins has also
een described. For instance, Zhao et al. [33], reported protective
ffects of the saponin Dioscin against acetominophem genotoxicity
n HepG2 cells, using a series of assays, including comet assay. Until
ow, no information in literature about genotoxic and/or muta-
enic effects of Hecogenin has been described.
In this work, a genotoxic effect of Hecogenin in the whole
ange of concentrations tested was observed. However, the capa-
ility of inducing DNA damage was not related with the mutagenic
attern shown. In fact, a reduction in nuclear instability was
bserved. A dose-response reduction in MN  and NBUD frequency
as described. By taking these facts together, it is possible to
peculate a protective capacity of Hecogenin. The observed DNA
amage could be repaired, avoiding the occurrence of mutations,
nd also reducing the basal frequency of MNs  and NBUDs. These
acts could be related to the stimulation of the cellular repair com-
lex to correct the elicited damage cause by Hecogenin exposure.
hese observations could be interpreted as a protective capability
f Hecogenin, preventing the dissemination of the DNA damage in
ell division. This genotoxic and protective proﬁle has already been
ighlighted by other studies. Alves et al. [34] described extracts
rom saponin-rich medicinal plants which could cause DNA dam-
ge when analyzed separately and, at the same time, be a protective
gent when tested against mutagenic drugs in mice. Furthermore,
ernández-Herrera et al. [29,31] have demonstrated the role of
ecogenin on caspase activation, preventing the proliferation of
he damaged cells by apoptosis.
In this work, Hecogenin showed genotoxicity, but also a protec-
ive role against mutagenic effect on HepG2. These facts were in
greement with the aforementioned studies, reinforcing the idea
hat the apoptotic mechanism is triggered by Hecogenin to avoid
roliferation of genetic damage. More studies will have to be per-
ormed to conﬁrm this hypothesis.
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